<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00357227</url>
  </required_header>
  <id_info>
    <org_study_id>01 GI 0204</org_study_id>
    <nct_id>NCT00357227</nct_id>
  </id_info>
  <brief_title>Atrial Fibrillation and the Risk for Neurological Complications</brief_title>
  <official_title>Atrial Fibrillation and the Risk for Neurological Complications</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Muenster</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>German Federal Ministry of Education and Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Muenster</source>
  <brief_summary>
    <textblock>
      B8: Atrial fibrillation and the risk of neurological complications&#xD;
&#xD;
      Twenty-five thousand acute strokes are caused by atrial fibrillation every year. But even&#xD;
      more frequent than symptomatic strokes are silent infarctions of the brain. Silent strokes&#xD;
      remain undetected in most cases, but cumulate over time and progressively impair cognition.&#xD;
      The impact of atrial fibrillation on subacute brain infarctions is not yet known. Moreover,&#xD;
      it has not been elucidated so far how effective different therapeutic strategies in the&#xD;
      treatment of atrial fibrillation prevent cognitive impairment. Thus, this study aims at&#xD;
      evaluating the influence of different types of atrial fibrillation on silent strokes and the&#xD;
      related impairment in cognitive functions. Other risk factors and cardiovascular diseases&#xD;
      that are known to provoke the development of strokes will be assessed as well. So, it will be&#xD;
      possible to isolate the contribution of atrial fibrillation to silent strokes and related&#xD;
      cognitive impairment in segregation to other relevant factors. AF patients and controls will&#xD;
      be examined twice in two years in order to evaluate the role of atrial fibrillation and&#xD;
      differential therapeutic interventions with regard to the progression of silent strokes and&#xD;
      cognitive impairment in a within subject-design.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2004</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Defined Population</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment>1000</enrollment>
  <condition>Atrial Fibrillation</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Clinical diagnosis of permanent, paroxysmal or episodic atrial fibrillation in the&#xD;
             past or at present&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pacemaker&#xD;
&#xD;
          -  Metal implants&#xD;
&#xD;
          -  History of acute stroke&#xD;
&#xD;
          -  Diagnosis of vascular or degenerative dementia&#xD;
&#xD;
          -  History of brain tumors&#xD;
&#xD;
          -  History of severe brain injury&#xD;
&#xD;
          -  History of psychiatric disorders&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefan Knecht, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Münster, Department of Neurology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stefan Knecht, Prof.</last_name>
    <phone>+49-251-83-</phone>
    <phone_ext>48195</phone_ext>
    <email>knecht@uni-muenster.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Münster, Dept. of Neurology</name>
      <address>
        <city>Münster</city>
        <state>NRW</state>
        <zip>48149</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Stefan Knecht, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://neurologie.uni-muenster.de/cms/front_content.php</url>
    <description>University Hospital Muenster, Dept. of Neurology</description>
  </link>
  <verification_date>April 2007</verification_date>
  <study_first_submitted>July 25, 2006</study_first_submitted>
  <study_first_submitted_qc>July 25, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 27, 2006</study_first_posted>
  <last_update_submitted>April 18, 2007</last_update_submitted>
  <last_update_submitted_qc>April 18, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 19, 2007</last_update_posted>
  <keyword>Atrial fibrillation</keyword>
  <keyword>Stroke</keyword>
  <keyword>Vascular Dementia</keyword>
  <keyword>Mild Cognitive Impairment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

